EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD28-driven ex vivo generation of stem-like memory CD8 + T cells bypassing CD3/TCR signaling

Fumie Ihara, Yota Ohashi, Evey Y F Zheng, Saori Fukao, Rowena Rodrigo, Babak Noamani, Giselle M Boukhaled, Ben X Wang, Dong-Hoon Han, Xinyu Wei, Brian D Burt, Kayoko Saso und 7 weitere

Proceedings of the National Academy of Sciences · 28.04.2026 · 123 (17)

DOI: 10.1073/pnas.2524626123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 21.04.2026. Verfasst von Fumie Ihara und 18 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada. Hauptthemen laut MEDLINE: CD28 Antigens, CD8-Positive T-Lymphocytes, CD3 Complex, Immunologic Memory. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Ontario Institute for Cancer Research (OICR), Longo Family Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive T cell therapies typically rely on ex vivo CD3/CD28 stimulation, which promotes effector differentiation and limits the persistence of transferred cells. Stem cell–like memory T cells (Tscm), with their capacity for self-renewal and multipotency, represent an ideal therapeutic subset but remain difficult to generate at scale. Here, we present a CD3-independent strategy using artificial antigen-presenting cells expressing a membrane-bound CD28 superagonist (αCD28-aAPCs) to expand CD8 + T cells with Tscm-like features. In naïve CD8 + T cells, αCD28-aAPC stimulation initiates a distinct transcriptional and epigenetic program, marked by high TCF1 expression, metabolic fitness, and resistance to exhaustion—key hallmarks of the Tscm phenotype. Mechanistically, this approach circumvents canonical CD3/TCR signaling and notably avoids induction of IRF4, a key transcription factor that drives BLIMP1 upregulation, TCF1 downregulation, and glycolytic commitment during effector differentiation. Instead, sustained CD28 signaling alone reprograms T cells toward a Tscm-like state. Upon subsequent antigen encounter and CD3 engagement, these αCD28-aAPC-expanded T cells mount robust effector responses while retaining superior persistence and antitumor activity in preclinical models. Our findings reveal an underappreciated role of CD28 signaling in guiding Tscm-like fate through IRF4 suppression and establish a platform for generating durable and functionally potent T cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD28 AntigensCD8-Positive T-LymphocytesCD3 ComplexImmunologic MemoryReceptors, Antigen, T-CellMemory T CellsAnimalsSignal TransductionCell DifferentiationHepatocyte Nuclear Factor 1-alphaMiceT-Cell ExhaustionInterferon Regulatory Factor-4Interferon Regulatory FactorsAntigen-Presenting CellsPositive Regulatory Domain I-Binding Factor 1Mice, Inbred C57BLLymphocyte Activation

Stichwörter der Autor:innen

CD28 signalingCD3-independent activationadoptive T cell therapyartificial antigen-presenting cellsstem cell–like memory T cells

Substanzen

CD28 AntigensCD3 ComplexReceptors, Antigen, T-CellHepatocyte Nuclear Factor 1-alphaHnf1a protein, mouseInterferon Regulatory Factor-4Interferon Regulatory FactorsPositive Regulatory Domain I-Binding Factor 1

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
  • Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University, Tokyo 160-8582, Japan.
  • Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong Special Administrative Region, China.
  • Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

ORCID-Profile: Tak W Mak, Naoto Hirano

Förderung

  • Canadian Institutes of Health Research (CIHR)
  • Ontario Institute for Cancer Research (OICR)
  • Longo Family Cancer Foundation
  • Princess Margaret Cancer Foundation (PMCF)
  • Amgen Chair in Cancer Research
  • Canada Research Chairs (CRC)

Zitieren

APA

Ihara, F., Ohashi, Y., Zheng, E. Y. F., Fukao, S., Rodrigo, R., Noamani, B., Boukhaled, G. M., Wang, B. X., Han, D. H., Wei, X., Burt, B. D., Saso, K., Matsunaga, Y., Ly, D., Kagoya, Y., Butler, M. O., Mak, T. W., Saibil, S. D., & Hirano, N. (2026). CD28-driven ex vivo generation of stem-like memory CD8 + T cells bypassing CD3/TCR signaling. Proceedings of the National Academy of Sciences, 123(17). https://doi.org/10.1073/pnas.2524626123

Vancouver

Ihara F, Ohashi Y, Zheng EYF, Fukao S, Rodrigo R, Noamani B, et al. CD28-driven ex vivo generation of stem-like memory CD8 + T cells bypassing CD3/TCR signaling. Proceedings of the National Academy of Sciences. 2026;123(17). doi:10.1073/pnas.2524626123

BibTeX
@article{Ihara2026,
  author = {Ihara, Fumie and Ohashi, Yota and Zheng, Evey Y F and Fukao, Saori and Rodrigo, Rowena and Noamani, Babak and Boukhaled, Giselle M and Wang, Ben X and Han, Dong-Hoon and Wei, Xinyu and Burt, Brian D and Saso, Kayoko and Matsunaga, Yukiko and Ly, Dalam and Kagoya, Yuki and Butler, Marcus O and Mak, Tak W and Saibil, Samuel D and Hirano, Naoto},
  title = {CD28-driven ex vivo generation of stem-like memory CD8 + T cells bypassing CD3/TCR signaling},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {17},
  doi = {10.1073/pnas.2524626123}
}
Kostenlos starten →